D.C. Circuit Rejects Administration’s Rule Requiring List Prices in Drug Ads
- June 19, 2020
The D.C. Circuit rejected June 16 rejected the administration’s final rule requiring pharmaceutical manufacturers to include a drug's list price in direct-to-consumer television advertisements.
You must be logged in to access this content.